Cargando…
Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
Ankylosing Spondylitis (AS) is a common inflammatory rheumatic disease with a predilection for the axial skeleton, affecting 0.2% of the population. Current diagnostic criteria rely on a composite of clinical and radiological changes, with a mean time to diagnosis of 5 to 10 years. In this study we...
Autores principales: | Fischer, Roman, Trudgian, David C., Wright, Cynthia, Thomas, Gethin, Bradbury, Linda A., Brown, Matthew A., Bowness, Paul, Kessler, Benedikt M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277768/ https://www.ncbi.nlm.nih.gov/pubmed/21997733 http://dx.doi.org/10.1074/mcp.M111.013904 |
Ejemplares similares
-
Two birds with one stone: Doing metabolomics with your proteomics kit
por: Fischer, Roman, et al.
Publicado: (2013) -
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
por: Nancy, Zaarour, et al.
Publicado: (2021) -
New developments in our understanding of ankylosing spondylitis pathogenesis
por: Voruganti, Aniruddha, et al.
Publicado: (2020) -
Progress in our understanding of the pathogenesis of ankylosing spondylitis
por: Simone, Davide, et al.
Publicado: (2018) -
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
por: Hwang, Mark, et al.
Publicado: (2023)